Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001104659-15-081130

Director acquired 3,502 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Saad Mark E Director 2015-11-24 Conversion +3,502 $5.94 $20,802 3,502 D
Derivatives
Saad Mark E Director 2015-11-24 Grant or award · 8% Convertible Note +3,502 0 D
Loading xslF345X03/a4.xml…